by
Nicholas S. Hill, Harrison W. FarberNicholas S. Hill, Harrison W. Farber
*Pathophysiology and therapy of pulmonary hypertension have had enormous developments over the past decade *Discoveries of endothelin excess as well as prostacyclin and nitric oxide deficiency have led to important therapeutic insights *Identification of genes associated with pulmonary hypertension has begun to open the door to pathophysiologic insights *Expert authors describe new therapies that have led to significant improvements in patient function, quality of life, and survival This timely volume addresses the areas of pathophysiology and therapy of pulmonary hypertension, which have seen exciting developments over the past decade. The discoveries of endothelin overexpression as well as prostacyclin and nitric oxide deficiency in association with pulmonary hypertension have led to important therapeutic insights. In addition, the identification of genes associated with pulmonary hypertension has just begun to open the door to new pathophysiologic insights. The new therapies have led to significant improvements in patient function, quality of life and survival. This book will be of interest not only to cardiologists, pulmonary specialists and rheumatologists, but also many nurses and pharmacotherapists are becoming increasingly involved in the therapy of patients with pulmonary hypertension. Written for: Cardiologists, pulmonologists, rheumatologists
Product Details
ISBN-13: | 9781588296610 | |
Publisher: | Springer-Verlag New York, LLC | |
Publication date: | 07/17/2008 | |
Series: | Contemporary Cardiology Series | |
Edition description: | 2008 | |
Pages: | 444 | |
Product dimensions: | 6.10(w) x 9.30(h) x 1.00(d) |
Reviews
There are no reviews yet.